News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
600,317 Results
Type
Article (43101)
Company Profile (318)
Press Release (556898)
Multimedia
Podcasts (71)
Webinars (11)
Section
Business (168006)
Career Advice (2445)
Deals (30367)
Drug Delivery (108)
Drug Development (78812)
Employer Resources (148)
FDA (14448)
Job Trends (13013)
News (296530)
Policy (28577)
Tag
Academia (2680)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (88)
Alliances (43009)
ALS (103)
Alzheimer's disease (1452)
Antibody-drug conjugate (ADC) (151)
Approvals (14428)
Artificial intelligence (268)
Autoimmune disease (27)
Automation (17)
Bankruptcy (326)
Best Places to Work (10684)
BIOSECURE Act (16)
Biosimilars (97)
Biotechnology (259)
Bladder cancer (86)
Brain cancer (29)
Breast cancer (296)
Cancer (2348)
Cardiovascular disease (197)
Career advice (2056)
Career pathing (32)
CAR-T (163)
Cell therapy (453)
Cervical cancer (19)
Clinical research (64019)
Collaboration (851)
Company closure (2)
Compensation (412)
Complete response letters (25)
COVID-19 (2572)
CRISPR (49)
C-suite (269)
Cystic fibrosis (103)
Data (2320)
Decentralized trials (2)
Denatured (15)
Depression (54)
Diabetes (272)
Diagnostics (5848)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (40)
Drug discovery (123)
Drug pricing (106)
Drug shortages (23)
Duchenne muscular dystrophy (102)
Earnings (62241)
Editorial (42)
Employer branding (20)
Employer resources (135)
Events (90326)
Executive appointments (760)
FDA (15769)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (753)
Gene editing (119)
Generative AI (21)
Gene therapy (344)
GLP-1 (751)
Government (4270)
Grass and pollen (5)
Guidances (152)
Healthcare (17275)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (143)
Indications (30)
Infectious disease (2722)
Inflammatory bowel disease (154)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (100)
Interviews (524)
IPO (14280)
IRA (45)
Job creations (2760)
Job search strategy (1683)
Kidney cancer (11)
Labor market (25)
Layoffs (470)
Leadership (23)
Legal (6075)
Liver cancer (77)
Lung cancer (335)
Lymphoma (151)
Machine learning (9)
Management (52)
Manufacturing (301)
MASH (83)
Medical device (11151)
Medtech (11155)
Mergers & acquisitions (16625)
Metabolic disorders (727)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (110)
Neuropsychiatric disorders (34)
Neuroscience (2043)
NextGen: Class of 2025 (5970)
Non-profit (4122)
Now hiring (36)
Obesity (377)
Opinion (236)
Ovarian cancer (81)
Pain (95)
Pancreatic cancer (88)
Parkinson's disease (159)
Partnered (20)
Patents (239)
Patient recruitment (114)
Peanut (48)
People (54337)
Pharmaceutical (55)
Pharmacy benefit managers (14)
Phase I (20104)
Phase II (28286)
Phase III (21052)
Pipeline (1360)
Policy (150)
Postmarket research (2391)
Preclinical (8522)
Press Release (60)
Prostate cancer (109)
Psychedelics (37)
Radiopharmaceuticals (258)
Rare diseases (415)
Real estate (4503)
Recruiting (60)
Regulatory (20391)
Reports (26)
Research institute (2280)
Resumes & cover letters (359)
Rett syndrome (6)
RNA editing (5)
RSV (40)
Schizophrenia (78)
Series A (130)
Series B (89)
Service/supplier (3)
Sickle cell disease (56)
Special edition (15)
Spinal muscular atrophy (153)
Sponsored (28)
Startups (3188)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (39)
The Weekly (55)
Vaccines (677)
Venture capitalists (41)
Weight loss (256)
Women's health (28)
Worklife (17)
Date
Today (60)
Last 7 days (938)
Last 30 days (2852)
Last 365 days (31055)
2025 (11223)
2024 (33634)
2023 (37498)
2022 (48412)
2021 (52024)
2020 (50008)
2019 (42544)
2018 (32072)
2017 (29660)
2016 (28193)
2015 (32972)
2014 (25387)
2013 (20574)
2012 (21784)
2011 (22690)
2010 (20430)
Location
Africa (743)
Alabama (56)
Alaska (4)
Arizona (171)
Arkansas (12)
Asia (36464)
Australia (7236)
California (5952)
Canada (1983)
China (521)
Colorado (254)
Connecticut (245)
Delaware (156)
Europe (81912)
Florida (882)
Georgia (190)
Idaho (55)
Illinois (497)
India (24)
Indiana (284)
Iowa (8)
Japan (168)
Kansas (96)
Kentucky (22)
Louisiana (11)
Maine (52)
Maryland (872)
Massachusetts (4420)
Michigan (207)
Minnesota (355)
Mississippi (2)
Missouri (79)
Montana (24)
Nebraska (22)
Nevada (60)
New Hampshire (66)
New Jersey (1700)
New Mexico (25)
New York (1679)
North Carolina (941)
North Dakota (6)
Northern California (2578)
Ohio (183)
Oklahoma (10)
Oregon (33)
Pennsylvania (1292)
Puerto Rico (13)
Rhode Island (30)
South America (1016)
South Carolina (22)
South Dakota (1)
Southern California (2299)
Tennessee (93)
Texas (867)
United States (22192)
Utah (183)
Virginia (142)
Washington D.C. (58)
Washington State (531)
West Virginia (3)
Wisconsin (49)
600,317 Results for "aquestive therapeutics formerly known as monosolrx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
May 5, 2025
·
3 min read
Press Releases
Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
April 9, 2025
·
2 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Aquestive Therapeutics to Participate in Two Upcoming Conferences in March
February 26, 2025
·
3 min read
Press Releases
Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Conference
February 4, 2025
·
3 min read
Pharm Country
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Aquestive Therapeutics, Inc. announced that the Aquestive management team will participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism and host investor meetings on July 9, 2024.
June 27, 2024
·
2 min read
Press Releases
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 5, 2025
·
38 min read
Press Releases
Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET
May 1, 2025
·
3 min read
Press Releases
Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives
January 14, 2025
·
19 min read
Business
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Aquestive Therapeutics, Inc. today announced the appointment of Abigail Jenkins to the Company’s Board of Directors, effective April 1, 2024.
April 1, 2024
·
6 min read
1 of 60,032
Next
